Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation

Although the incidence of bleeding complications during extracorporeal membrane oxygenator (ECMO) support has decreased in various trials, bleeding is still the most fatal complication. We investigated the ideal dosage and efficacy of nafamostat mesilate for use with ECMO in patients with acute card...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sang Jin, Kim, Hyoung Soo, Kim, Kun Il, Whang, Sung Mi, Hong, Kyung Soon, Lee, Won Ki, Lee, Sun Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124727/
https://www.ncbi.nlm.nih.gov/pubmed/21738350
http://dx.doi.org/10.3346/jkms.2011.26.7.945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124727/
https://www.ncbi.nlm.nih.gov/pubmed/21738350
http://dx.doi.org/10.3346/jkms.2011.26.7.945

Ejemplares similares